Article
Analysis of the DPYD gene implicated in 5-fluorouracil catabolism in a cohort of Caucasian individuals.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Aug 2005
Seck Katharina, Riemer Silvia, Kates Ronald, Ullrich Tobias, Lutz Verena, Harbeck Nadia, Schmitt Manfred, Kiechle Marion, Diasio Robert, Gross Eva
Abstract excerpt
PURPOSE: Complete or partial loss of dihydropyrimidine dehydrogenase (DPD) function has been described in cancer patients with intolerance to fluoropyrimidine drugs like 5-fluorouracil (5-FU) or Xeloda. The intention of this population study is to assess and to evaluate gene variations in the entire coding region of the dihydropyrimidine dehydrogenase gene (DPYD), which could be implicated in DPD malfunction....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
